October 28, 2016

AbbVie Increases Quarterly Dividend by 12.3 Percent

Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print

NORTH CHICAGO, Ill., Oct. 28, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 12.3 percent from $0.57 per share to $0.64 per share. 

The cash dividend is payable February 15, 2017 to stockholders of record at the close of business on January 13, 2017.

Since the company's inception in 2013, AbbVie has increased its dividend by 60 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view our Facebook and LinkedIn pages.

AbbVie logo

Logo - http://photos.prnewswire.com/prnh/20160706/386913LOGO

 

SOURCE AbbVie

Contact(s)


Media
Adelle Infante
(847) 938-8745
or
Investors
Liz Shea (847) 935-2211